deltatrials
Recruiting PHASE2 INTERVENTIONAL 2-arm NCT05482945

CardioPulmonary Resuscitation With Argon (CPAr) Trial (CPAr)

Sponsor: Mario Negri Institute for Pharmacological Research

Interventions Noble gas Argon
Updated 8 times since 2022 Last updated: Sep 11, 2025 Started: May 30, 2022 Primary completion: Mar 31, 2026 Completion: Jun 30, 2026
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE2 clinical study on Cardiac Arrest With Successful Resuscitation and Cardiac Arrest, Out-Of-Hospital, this trial is actively recruiting participants. The trial is conducted by Mario Negri Institute for Pharmacological Research and has accumulated 8 data snapshots since 2022. Cardiovascular trials of this type often inform treatment guidelines for long-term patient management.

Status Flow

~Sep 2022 – ~Feb 2024 · 17 months · monthly snapshotRecruiting~Feb 2024 – ~Jul 2024 · 5 months · monthly snapshotRecruiting~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshotRecruiting~Sep 2024 – ~Dec 2024 · 3 months · monthly snapshotRecruiting~Dec 2024 – ~Aug 2025 · 8 months · monthly snapshotRecruiting~Aug 2025 – ~Sep 2025 · 31 days · monthly snapshotRecruiting~Sep 2025 – ~Oct 2025 · 30 days · monthly snapshotRecruiting~Oct 2025 – present · 10 months · monthly snapshotRecruiting

Change History

8 versions recorded
  1. Oct 2025 — Present [monthly]

    Recruiting PHASE2

  2. Sep 2025 — Oct 2025 [monthly]

    Recruiting PHASE2

  3. Aug 2025 — Sep 2025 [monthly]

    Recruiting PHASE2

    Phase: NAPHASE2

  4. Dec 2024 — Aug 2025 [monthly]

    Recruiting NA

  5. Sep 2024 — Dec 2024 [monthly]

    Recruiting NA

Show 3 earlier versions
  1. Jul 2024 — Sep 2024 [monthly]

    Recruiting NA

  2. Feb 2024 — Jul 2024 [monthly]

    Recruiting NA

  3. Sep 2022 — Feb 2024 [monthly]

    Recruiting NA

    First recorded

May 2022

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Mario Negri Institute for Pharmacological Research
Data source: Mario Negri Institute for Pharmacological Research

For direct contact, visit the study record on ClinicalTrials.gov .